A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy
Public ClinicalTrials.gov record NCT04958031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether CVL-871 is safe and tolerable in patients with Dementia-Related Apathy and if CVL-871 shows changes in clinical measurements of apathy.
Study identification
- NCT ID
- NCT04958031
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2021 (Actual)
- Primary completion
- Feb 12, 2025 (Actual)
- Completion
- Feb 12, 2025 (Actual)
- Last update posted
- Mar 11, 2026
2021 – 2025
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale, Arizona | Scottsdale | Arizona | 85258 | — |
| Little Rock, Arkansas | Little Rock | Arkansas | 72114 | — |
| San Diego, California | San Diego | California | 92123 | — |
| Santa Ana, California | Santa Ana | California | 92705 | — |
| New Haven, Connecticut | New Haven | Connecticut | 06510 | — |
| Delray Beach, Florida | Delray Beach | Florida | 33445 | — |
| Miami, Florida | Miami | Florida | 33122 | — |
| Miami, Florida | Miami | Florida | 33180 | — |
| Orlando, Florida | Orlando | Florida | 32819 | — |
| Wellington, Florida | Wellington | Florida | 33414 | — |
| Decatur, Georgia | Decatur | Georgia | 30030 | — |
| Plymouth, Massachusetts | Plymouth | Massachusetts | 02360 | — |
| Staten Island, New York | Staten Island | New York | 10312 | — |
| Columbus, Ohio | Columbus | Ohio | 43210 | — |
| Abington, Pennsylvania | Abington | Pennsylvania | 19001 | — |
| Charleston, South Carolina | Charleston | South Carolina | 29403 | — |
| Fairfax, Virginia | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04958031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced Oct 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04958031 live on ClinicalTrials.gov.